Lagis Enterprise Co., Ltd. (TPEX:6730)
Taiwan · Delayed Price · Currency is TWD 36.35
-0.15 (-0.41%)
At close: Mar 26, 2026
Lagis Enterprise Revenue
In the year 2025, Lagis Enterprise had annual revenue of 487.65M TWD with 7.33% growth. Lagis Enterprise had revenue of 123.93M in the quarter ending December 31, 2025, with 16.29% growth.
Revenue
487.65M
Revenue Growth
+7.33%
P/S Ratio
2.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487.65M | 33.29M | 7.33% |
| Dec 31, 2024 | 454.36M | -5.58M | -1.21% |
| Dec 31, 2023 | 459.93M | 17.75M | 4.01% |
| Dec 31, 2022 | 442.19M | 49.15M | 12.50% |
| Dec 31, 2021 | 393.04M | 73.68M | 23.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.25B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bionime | 1.84B |
| Chi Sheng Pharma & Biotech | 1.38B |
| ICARES Medicus | 1.13B |
| Concord Medical | 964.35M |
| Crystalvue Medical | 949.05M |
| Maxigen Biotech | 811.56M |